The Cellular Phase of Alzheimer's Disease

Cell

Volumn 164, Issue 4, 2016, Pages 603-615

  De Strooper, Bart ^a,b,c   Karran, Eric ^b,c,d  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Alzheimer's Research UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ASSOCIATED PROTEIN; CD36 ANTIGEN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; CYTOKINE; EPHRIN RECEPTOR A1; HLA DRB5 ANTIGEN; TOLL LIKE RECEPTOR 4; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; APOPTOSIS; ASTROCYTE; ASTROCYTOSIS; CELL FUNCTION; CELL POPULATION; CELLULAR PHASE; DEMYELINATION; DISEASE COURSE; HOMEOSTASIS; HUMAN; INFLAMMATION; MACROGLIA; MICROGLIA; MONOCYTE; NERVE CELL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REVIEW; SENILE PLAQUE; SINGLE CELL ANALYSIS; SMOOTH MUSCLE FIBER; TAUOPATHY; ANIMAL; BRAIN; METABOLISM; MOUSE; NERVE TRACT; PATHOLOGY; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BRAIN; HUMANS; MICE; MICROGLIA; NEURAL PATHWAYS; OLIGODENDROGLIA; SINGLE-CELL ANALYSIS;

EID: 84958225958     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.12.056     Document Type: Review

References (101)

1. N.J. Allen Astrocyte regulation of synaptic behavior Annu. Rev. Cell Dev. Biol. 30 2014 439 463
2. K. Ando, J.-P. Brion, V. Stygelbout, V. Suain, M. Authelet, R. Dedecker, A. Chanut, P. Lacor, J. Lavaur, V. Sazdovitch, and et al. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains Acta Neuropathol. 125 2013 861 878
3. Y. Atagi, C.-C. Liu, M.M. Painter, X.-F. Chen, C. Verbeeck, H. Zheng, X. Li, R. Rademakers, S.S. Kang, H. Xu, and et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) J. Biol. Chem. 290 2015 26043 26050
4. J. Attems, and K.A. Jellinger The overlap between vascular disease and Alzheimer's disease - lessons from pathology BMC Med. 12 2014 206
5. X.C. Bai, C. Yan, G. Yang, P. Lu, D. Ma, L. Sun, R. Zhou, S.H.W. Scheres, and Y. Shi An atomic structure of human γ-secretase Nature 525 2015 212 217
6. A. Bakker, G.L. Krauss, M.S. Albert, C.L. Speck, L.R. Jones, C.E. Stark, M.A. Yassa, S.S. Bassett, A.L. Shelton, and M. Gallagher Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment Neuron 74 2012 467 474
7. G. Bartzokis Alzheimer's disease as homeostatic responses to age-related myelin breakdown Neurobiol. Aging 32 2011 1341 1371
8. J. Beauquis, A. Vinuesa, C. Pomilio, P. Pavía, V. Galván, and F. Saravia Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease Hippocampus 24 2014 257 269
9. G. Behrendt, K. Baer, A. Buffo, M.A. Curtis, R.L. Faull, M.I. Rees, M. Götz, and L. Dimou Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men Glia 61 2013 273 286
10. R.D. Bell, E.A. Winkler, I. Singh, A.P. Sagare, R. Deane, Z. Wu, D.M. Holtzman, C. Betsholtz, A. Armulik, J. Sallstrom, and et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A Nature 485 2012 512 516
11. I. Benilova, E. Karran, and B. De Strooper The toxic Aβ oligomer and Alzheimer's disease: An emperor in need of clothes Nat. Neurosci. 15 2012 349 357
12. D.A. Bennett, L. Yu, and P.L. De Jager Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease Biochem. Pharmacol. 88 2014 617 630
13. K. Bossers, K.T.S. Wirz, G.F. Meerhoff, A.H.W. Essing, J.W. van Dongen, P. Houba, C.G. Kruse, J. Verhaagen, and D.F. Swaab Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease Brain 133 2010 3699 3723
14. H. Braak, and E. Braak Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol. Aging 16 1995 271 278 discussion 278-284
15. H. Braak, and E. Braak Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis Acta Neuropathol. 92 1996 197 201
16. H. Braak, and K. Del Tredici The pathological process underlying Alzheimer's disease in individuals under thirty Acta Neuropathol. 121 2011 171 181
17. J.E. Burda, and M.V. Sofroniew Reactive gliosis and the multicellular response to CNS damage and disease Neuron 81 2014 229 248
18. E.A. Bushong, M.E. Martone, Y.Z. Jones, and M.H. Ellisman Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains J. Neurosci. 22 2002 183 192
19. M.C. Carrillo, R.A. Dean, F. Nicolas, D.S. Miller, R. Berman, Z. Khachaturian, L.J. Bain, R. Schindler, D. Knopman Alzheimer's Association Research Roundtable Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria Alzheimers Dement. 9 2013 594 601
20. S.F. Carter, M. Schöll, O. Almkvist, A. Wall, H. Engler, B. Långström, and A. Nordberg Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG J. Nucl. Med. 53 2012 37 46
21. P. Chakrabarty, A. Li, C. Ceballos-Diaz, J.A. Eddy, C.C. Funk, B. Moore, N. DiNunno, A.M. Rosario, P.E. Cruz, C. Verbeeck, and et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior Neuron 85 2015 519 533
22. L. Chávez-Gutiérrez, L. Bammens, I. Benilova, A. Vandersteen, M. Benurwar, M. Borgers, S. Lismont, L. Zhou, S. Van Cleynenbreugel, H. Esselmann, and et al. The mechanism of γ-Secretase dysfunction in familial Alzheimer disease EMBO J. 31 2012 2261 2274
23. J. Cheng, and D. Ji Rigid firing sequences undermine spatial memory codes in a neurodegenerative mouse model eLife 2 2013 e00647
24. W.-S. Chung, L.E. Clarke, G.X. Wang, B.K. Stafford, A. Sher, C. Chakraborty, J. Joung, L.C. Foo, A. Thompson, C. Chen, and et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways Nature 504 2013 394 400
25. J.F. Crary, J.Q. Trojanowski, J.A. Schneider, J.F. Abisambra, E.L. Abner, I. Alafuzoff, S.E. Arnold, J. Attems, T.G. Beach, E.H. Bigio, and et al. Primary age-related tauopathy (PART): A common pathology associated with human aging Acta Neuropathol. 128 2014 755 766
26. A.H. Crawford, J.H. Stockley, R.B. Tripathi, W.D. Richardson, and R.J.M. Franklin Oligodendrocyte progenitors: Adult stem cells of the central nervous system? Exp. Neurol. 260 2014 50 55
27. D.H. Cribbs, N.C. Berchtold, V. Perreau, P.D. Coleman, J. Rogers, A.J. Tenner, and C.W. Cotman Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: A microarray study J. Neuroinflammation 9 2012 179
28. S. Darmanis, S.A. Sloan, Y. Zhang, M. Enge, C. Caneda, L.M. Shuer, M.G. Hayden Gephart, B.A. Barres, and S.R. Quake A survey of human brain transcriptome diversity at the single cell level Proc. Natl. Acad. Sci. USA 112 2015 7285 7290
29. B. De Strooper Proteases and proteolysis in Alzheimer disease: A multifactorial view on the disease process Physiol. Rev. 90 2010 465 494
30. B. De Strooper Lessons from a failed γ-secretase Alzheimer trial Cell 159 2014 721 726
31. R. Deane, I. Singh, A.P. Sagare, R.D. Bell, N.T. Ross, B. LaRue, R. Love, S. Perry, N. Paquette, R.J. Deane, and et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease J. Clin. Invest. 122 2012 1377 1392
32. M.K. Desai, M.A. Mastrangelo, D.A. Ryan, K.L. Sudol, W.C. Narrow, and W.J. Bowers Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target Am. J. Pathol. 177 2010 1422 1435
33. B. Dubois, H.H. Feldman, C. Jacova, H. Hampel, J.L. Molinuevo, K. Blennow, S.T. DeKosky, S. Gauthier, D. Selkoe, R. Bateman, and et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Lancet Neurol. 13 2014 614 629
34. M.J. Elrick, T. Yu, C. Chung, and A.P. Lieberman Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease Hum. Mol. Genet. 21 2012 4876 4887
35. B. Ettle, J.C.M. Schlachetzki, and J. Winkler Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders? Mol. Neurobiol. 2015 10.1007/s12035-015-9205-3 Published online May 13, 2015
36. A.H. Gittis, and D.J. Brasier NEUROSCIENCE. Astrocytes tell neurons when to listen up Science 349 2015 690 691
37. S.A. Grathwohl, R.E. Kälin, T. Bolmont, S. Prokop, G. Winkelmann, S. Kaeser, J. Odenthal, R. Radde, T. Eldh, S. Gandy, and et al. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia Nat. Neurosci. 12 2010 1361 1363
38. A. Griciuc, A. Serrano-Pozo, A.R. Parrado, A.N. Lesinski, C.N. Asselin, K. Mullin, B. Hooli, S.H. Choi, B.T. Hyman, and R.E. Tanzi Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta Neuron 78 2013 631 643
39. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, C. Cruchaga, C. Sassi, J.S.K. Kauwe, S. Younkin, et al. Alzheimer Genetic Analysis Group TREM2 variants in Alzheimer's disease N. Engl. J. Med. 368 2013 117 127
40. M.-V. Guillot-Sestier, K.R. Doty, D. Gate, J. Rodriguez Jr., B.P. Leung, K. Rezai-Zadeh, and T. Town Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology Neuron 85 2015 534 548
41. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
42. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, I. Dewachter, J. Walter, T. Klockgether, and F. Van Leuven Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice J. Neuroinflammation 2 2005 22
43. M.T. Heneka, M.J. Carson, J. El Khoury, G.E. Landreth, F. Brosseron, D.L. Feinstein, A.H. Jacobs, T. Wyss-Coray, J. Vitorica, R.M. Ransohoff, and et al. Neuroinflammation in Alzheimer's disease Lancet Neurol. 14 2015 388 405
44. S.E. Hickman, and J. El Khoury TREM2 and the neuroimmunology of Alzheimer's disease Biochem. Pharmacol. 88 2014 495 498
45. J.J. Iliff, M.J. Chen, B.A. Plog, D.M. Zeppenfeld, M. Soltero, L. Yang, I. Singh, R. Deane, and M. Nedergaard Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury J. Neurosci. 34 2014 16180 16193
46. S. Jo, O. Yarishkin, Y.J. Hwang, Y.E. Chun, M. Park, D.H. Woo, J.Y. Bae, T. Kim, J. Lee, H. Chun, and et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease Nat. Med. 20 2014 886 896
47. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, J. Snaedal, S. Bjornsson, J. Huttenlocher, A.I. Levey, J.J. Lah, and et al. Variant of TREM2 associated with the risk of Alzheimer's disease N. Engl. J. Med. 368 2013 107 116
48. W. Kamphuis, L. Kooijman, M. Orre, O. Stassen, M. Pekny, and E.M. Hol GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease Glia 63 2015 1036 1056
49. C.M. Karch, and A.M. Goate Alzheimer's disease risk genes and mechanisms of disease pathogenesis Biol. Psychiatry 77 2015 43 51
50. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics Nat. Rev. Drug Discov. 10 2011 698 712
51. U.A. Khan, L. Liu, F.A. Provenzano, D.E. Berman, C.P. Profaci, R. Sloan, R. Mayeux, K.E. Duff, and S.A. Small Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease Nat. Neurosci. 17 2014 304 311
52. G. Kleinberger, Y. Yamanishi, M. Suárez-Calvet, E. Czirr, E. Lohmann, E. Cuyvers, H. Struyfs, N. Pettkus, A. Wenninger-Weinzierl, F. Mazaheri, and et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis Sci. Transl. Med. 6 2014 243ra86
53. M. Komatsu, S. Waguri, T. Chiba, S. Murata, J. Iwata, I. Tanida, T. Ueno, M. Koike, Y. Uchiyama, E. Kominami, and K. Tanaka Loss of autophagy in the central nervous system causes neurodegeneration in mice Nature 441 2006 880 884
54. A.W. Kraft, X. Hu, H. Yoon, P. Yan, Q. Xiao, Y. Wang, S.C. Gil, J. Brown, U. Wilhelmsson, J.L. Restivo, and et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice FASEB J. 27 2013 187 198
55. K.V. Kuchibhotla, C.R. Lattarulo, B.T. Hyman, and B.J. Bacskai Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice Science 323 2009 1211 1215
56. M. Kulijewicz-Nawrot, A. Verkhratsky, A. Chvátal, E. Syková, and J.J. Rodríguez Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease J. Anat. 221 2012 252 262
57. I. Kuperstein, K. Broersen, I. Benilova, J. Rozenski, W. Jonckheere, M. Debulpaep, A. Vandersteen, I. Segers-Nolten, K. Van Der Werf, V. Subramaniam, and et al. Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio EMBO J. 29 2010 3408 3420
58. J. Labbadia, and R.I. Morimoto The biology of proteostasis in aging and disease Annu. Rev. Biochem. 84 2015 435 464
59. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, A.L. DeStafano, J.C. Bis, G.W. Beecham, B. Grenier-Boley, et al. European Alzheimer's Disease Initiative (EADI) Genetic and Environmental Risk in Alzheimer's Disease Alzheimer's Disease Genetic Consortium Cohorts for Heart and Aging Research in Genomic Epidemiology Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat. Genet. 45 2013 1452 1458
60. P. Lau, K. Bossers, R. Janky, E. Salta, C.S. Frigerio, S. Barbash, R. Rothman, A.S.R. Sierksma, A. Thathiah, D. Greenberg, and et al. Alteration of the microRNA network during the progression of Alzheimer's disease EMBO Mol. Med. 5 2013 1613 1634
61. L.J. Lawson, V.H. Perry, P. Dri, and S. Gordon Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 39 1990 151 170
62. Y. Li, X.F. Du, C.S. Liu, Z.L. Wen, and J.L. Du Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo Dev. Cell 23 2012 1189 1202
63. H. Lian, L. Yang, A. Cole, L. Sun, A.C. Chiang, S.W. Fowler, D.J. Shim, J. Rodriguez-Rivera, G. Taglialatela, J.L. Jankowsky, and et al. NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease Neuron 85 2015 101 115
64. T. Lu, L. Aron, J. Zullo, Y. Pan, H. Kim, Y. Chen, T.-H. Yang, H.-M. Kim, D. Drake, X.S. Liu, and et al. REST and stress resistance in ageing and Alzheimer's disease Nature 507 2014 448 454
65. M. Matarin, D.A. Salih, M. Yasvoina, D.M. Cummings, S. Guelfi, W. Liu, M.A. Nahaboo Solim, T.G. Moens, R.M. Paublete, S.S. Ali, and et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology Cell Rep. 10 2015 633 644
66. P.L. McGeer, S. Itagaki, H. Tago, and E.G. McGeer Occurrence of HLA-DR reactive microglia in Alzheimer's disease Ann. N Y Acad. Sci. 540 1988 319 323
67. N. Menkes-Caspi, H.G. Yamin, V. Kellner, T.L. Spires-Jones, D. Cohen, and E.A. Stern Pathological tau disrupts ongoing network activity Neuron 85 2015 959 966
68. M.-M. Mesulam Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles Neuron 24 1999 521 529
69. J.A. Miller, S. Horvath, and D.H. Geschwind Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways Proc. Natl. Acad. Sci. USA 107 2010 12698 12703
70. E.J. Mufson, L. Mahady, D. Waters, S.E. Counts, S.E. Perez, S.T. DeKosky, S.D. Ginsberg, M.D. Ikonomovic, S.W. Scheff, and L.I. Binder Hippocampal plasticity during the progression of Alzheimer's disease Neuroscience 309 2015 51 67
71. P. Nilsson, T. Saito, and T.C. Saido New mouse model of Alzheimer's ACS Chem. Neurosci. 5 2014 499 502
72. R.A. Nixon The role of autophagy in neurodegenerative disease Nat. Med. 19 2013 983 997
73. M. Olabarria, H.N. Noristani, A. Verkhratsky, and J.J. Rodríguez Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease Glia 58 2010 831 838
74. A.G. Orr, E.C. Hsiao, M.M. Wang, K. Ho, D.H. Kim, X. Wang, W. Guo, J. Kang, G.-Q. Yu, A. Adame, and et al. Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory Nat. Neurosci. 18 2015 423 434
75. M. Orre, W. Kamphuis, L.M. Osborn, A.H.P. Jansen, L. Kooijman, K. Bossers, and E.M. Hol Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction Neurobiol. Aging 35 2014 2746 2760
76. J.J. Palop, and L. Mucke Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks Nat. Neurosci. 13 2010 812 818
77. D.P. Pelvig, H. Pakkenberg, L. Regeur, S. Oster, and B. Pakkenberg Neocortical glial cell numbers in Alzheimer's disease. A stereological study Dement. Geriatr. Cogn. Disord. 16 2003 212 219
78. D.P. Pelvig, H. Pakkenberg, A.K. Stark, and B. Pakkenberg Neocortical glial cell numbers in human brains Neurobiol. Aging 29 2008 1754 1762
79. H.D. Protas, K. Chen, J.B. Langbaum, A.S. Fleisher, G.E. Alexander, W. Lee, D. Bandy, M.J. de Leon, L. Mosconi, S. Buckley, and et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease JAMA Neurol. 70 2013 320 325
80. T. Saito, T. Suemoto, N. Brouwers, K. Sleegers, S. Funamoto, N. Mihira, Y. Matsuba, K. Yamada, P. Nilsson, J. Takano, and et al. Potent amyloidogenicity and pathogenicity of Aβ43 Nat. Neurosci. 14 2011 1023 1032
81. M.W. Salter, and S. Beggs Sublime microglia: expanding roles for the guardians of the CNS Cell 158 2014 15 24
82. R. Sandberg Entering the era of single-cell transcriptomics in biology and medicine Nat. Methods 11 2014 22 24
83. J.A. Santiago, and J.A. Potashkin A network approach to clinical intervention in neurodegenerative diseases Trends Mol. Med. 20 2014 694 703
84. P. Scheltens, F. Barkhof, J. Valk, P.R. Algra, R.G. van der Hoop, J. Nauta, and E.C. Wolters White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity Brain 115 1992 735 748
85. S.A. Small, and K. Duff Linking Abeta and tau in late-onset Alzheimer's disease: A dual pathway hypothesis Neuron 60 2008 534 542
86. M. Szaruga, S. Veugelen, M. Benurwar, S. Lismont, D. Sepulveda-Falla, A. Lleo, N.S. Ryan, T. Lashley, N.C. Fox, S. Murayama, and et al. Qualitative changes in human γ-secretase underlie familial Alzheimer's disease J. Exp. Med. 212 2015 2003 2013
87. J.M. Tarasoff-Conway, R.O. Carare, R.S. Osorio, L. Glodzik, T. Butler, E. Fieremans, L. Axel, H. Rusinek, C. Nicholson, B.V. Zlokovic, and et al. Clearance systems in the brain-implications for Alzheimer disease Nat. Rev. Neurol. 11 2015 457 470
88. D.R. Thal, U. Rüb, M. Orantes, and H. Braak Phases of A beta-deposition in the human brain and its relevance for the development of AD Neurology 58 2002 1791 1800
89. J.D. Ulrich, M.B. Finn, Y. Wang, A. Shen, T.E. Mahan, H. Jiang, F.R. Stewart, L. Piccio, M. Colonna, and D.M. Holtzman Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 Mol. Neurodegener. 9 2014 20
90. P.B. Verghese, J.M. Castellano, K. Garai, Y. Wang, H. Jiang, A. Shah, G. Bu, C. Frieden, and D.M. Holtzman ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions Proc. Natl. Acad. Sci. USA 110 2013 E1807 E1816
91. L. Verret, E.O. Mann, G.B. Hang, A.M.I. Barth, I. Cobos, K. Ho, N. Devidze, E. Masliah, A.C. Kreitzer, I. Mody, and et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model Cell 149 2012 708 721
92. L.C. Walker, and M. Jucker Neurodegenerative diseases: expanding the prion concept Annu. Rev. Neurosci. 38 2015 87 103
93. Y. Wang, M. Cella, K. Mallinson, J.D. Ulrich, K.L. Young, M.L. Robinette, S. Gilfillan, G.M. Krishnan, S. Sudhakar, B.H. Zinselmeyer, and et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model Cell 160 2015 1061 1071
94. E.A. Winkler, A.P. Sagare, and B.V. Zlokovic The pericyte: A forgotten cell type with important implications for Alzheimer's disease? Brain Pathol. 24 2014 371 386
95. E.A. Winkler, Y. Nishida, A.P. Sagare, S.V. Rege, R.D. Bell, D. Perlmutter, J.D. Sengillo, S. Hillman, P. Kong, A.R. Nelson, and et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration Nat. Neurosci. 18 2015 521 530
96. K. Yamada, J.K. Holth, F. Liao, F.R. Stewart, T.E. Mahan, H. Jiang, J.R. Cirrito, T.K. Patel, K. Hochgräfe, E.-M. Mandelkow, and D.M. Holtzman Neuronal activity regulates extracellular tau in vivo J. Exp. Med. 211 2014 387 393
97. K.R. Zahs, and K.H. Ashe 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci. 33 2010 381 389
98. A. Zeisel, A.B. Muñoz-Manchado, S. Codeluppi, P. Lönnerberg, G. La Manno, A. Juréus, S. Marques, H. Munguba, L. He, C. Betsholtz, and et al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq Science 347 2015 1138 1142
99. B. Zhang, C. Gaiteri, L.-G. Bodea, Z. Wang, J. McElwee, A.A. Podtelezhnikov, C. Zhang, T. Xie, L. Tran, R. Dobrin, and et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720
100. Z. Zhao, A.P. Sagare, Q. Ma, M.R. Halliday, P. Kong, K. Kisler, E.A. Winkler, A. Ramanathan, T. Kanekiyo, G. Bu, and et al. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance Nat. Neurosci. 18 2015 978 987
101. B.V. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Nat. Rev. Neurosci. 12 2011 723 738